|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
|
WO2003080149A2
(en)
|
2002-03-20 |
2003-10-02 |
Mannkind Corporation |
Inhalation apparatus
|
|
PL1786784T3
(pl)
|
2004-08-20 |
2011-04-29 |
Mannkind Corp |
Kataliza syntezy diketopiperazyn
|
|
KR101644250B1
(ko)
|
2004-08-23 |
2016-07-29 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
|
CN104324362B
(zh)
|
2005-09-14 |
2018-04-24 |
曼金德公司 |
以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
|
|
IN2015DN00888A
(https=)
|
2006-02-22 |
2015-07-10 |
Mannkind Corp |
|
|
ES2396471T3
(es)
*
|
2007-12-13 |
2013-02-21 |
Novartis Ag |
Procedimiento para reducir la tendencia de una sal de glicopirronio a agregarse durante el almacenamiento
|
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
|
ES2929343T3
(es)
|
2008-06-13 |
2022-11-28 |
Mannkind Corp |
Inhalador de polvo seco accionado por aspiración para la administración de fármacos
|
|
KR101628410B1
(ko)
|
2008-06-20 |
2016-06-08 |
맨카인드 코포레이션 |
흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
|
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
|
DK2405963T3
(da)
|
2009-03-11 |
2013-12-16 |
Mannkind Corp |
Apparat, system og fremgangsmåde til at måle modstand i en inhalator
|
|
ES2617680T3
(es)
|
2009-04-09 |
2017-06-19 |
Novartis Ag |
Proceso para la preparación de sales de pirrolidinio
|
|
PL3111927T3
(pl)
|
2009-05-29 |
2020-06-29 |
Pearl Therapeutics, Inc. |
Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
|
|
US8815258B2
(en)
|
2009-05-29 |
2014-08-26 |
Pearl Therapeutics, Inc. |
Compositions, methods and systems for respiratory delivery of two or more active agents
|
|
CN104721825B
(zh)
|
2009-06-12 |
2019-04-12 |
曼金德公司 |
具有确定比表面积的二酮哌嗪颗粒
|
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
|
GB0921481D0
(en)
|
2009-12-08 |
2010-01-20 |
Vectura Ltd |
Process and product
|
|
BR112012015334A2
(pt)
*
|
2009-12-23 |
2016-03-15 |
Chiesi Farma Spa |
terapia combinada para doença pulmonar obstrutiva crônica
|
|
SG181870A1
(en)
|
2009-12-23 |
2012-07-30 |
Chiesi Farma Spa |
Aerosol formulation for copd
|
|
KR20120106753A
(ko)
*
|
2009-12-23 |
2012-09-26 |
키에시 파르마슈티시 엣스. 피. 에이. |
Ｃｏｐｄ용 에어로졸 제제
|
|
EP2515855B3
(en)
*
|
2009-12-23 |
2023-05-03 |
Chiesi Farmaceutici S.p.A. |
Combination therapy for COPD
|
|
RU2569852C2
(ru)
|
2010-06-14 |
2015-11-27 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Кристаллическая форма гликопиррония хлорида
|
|
EP2580194A1
(en)
*
|
2010-06-14 |
2013-04-17 |
Chiesi Farmaceutici S.p.A. |
Process for the preparation of glycopyrronium chloride
|
|
IL223742A
(en)
|
2010-06-21 |
2016-06-30 |
Mannkind Corp |
A dry powder inhaler and preparation for it
|
|
PE20130601A1
(es)
*
|
2010-08-03 |
2013-05-30 |
Chiesi Farma Spa |
Formulacion de polvo seco que comprende un inhidor de fosfodiesterasa
|
|
RU2580890C2
(ru)
*
|
2010-09-30 |
2016-04-10 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Применение стеарата магния в составах сухого порошка для ингаляции
|
|
JO3510B1
(ar)
|
2011-03-04 |
2020-07-05 |
Heptares Therapeutics Ltd |
استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
|
|
AU2012236150B2
(en)
|
2011-04-01 |
2016-03-31 |
Mannkind Corporation |
Blister package for pharmaceutical cartridges
|
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
|
US10220164B2
(en)
|
2011-07-13 |
2019-03-05 |
Pharmaxis Ltd. |
Delivery devices
|
|
US10786637B2
(en)
|
2011-07-13 |
2020-09-29 |
Pharmaxis Ltd. |
Delivery devices
|
|
ES2761316T3
(es)
|
2011-07-13 |
2020-05-19 |
Pharmaxis Ltd |
Mejoras relacionadas con dispositivos de suministro
|
|
BR112014009686A2
(pt)
|
2011-10-24 |
2018-08-07 |
Mannkind Corp |
composição analgésica inalável, pó seco e método para tratar dor
|
|
EA201590019A1
(ru)
*
|
2012-07-05 |
2015-09-30 |
Арвен Айлак Санайи Ве Тиджарет А.С. |
Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы
|
|
WO2014007767A1
(en)
*
|
2012-07-05 |
2014-01-09 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Dry powder inhalers comprising a carrier other than lactose and a ternary component
|
|
US10111957B2
(en)
|
2012-07-05 |
2018-10-30 |
Arven Ilac Snayi ve Ticaret A.S. |
Inhalation compositions comprising glucose anhydrous
|
|
US10105316B2
(en)
|
2012-07-05 |
2018-10-23 |
Arven llac Sanayi Ve Ticaret A.S. |
Inhalation compositions comprising muscarinic receptor antagonist
|
|
CN104619369B
(zh)
|
2012-07-12 |
2018-01-30 |
曼金德公司 |
干粉药物输送系统和方法
|
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
|
AU2013100007B4
(en)
*
|
2013-01-04 |
2013-05-23 |
Novartis Ag |
System for treating chronic obstructive pulmonary disease
|
|
US9452139B2
(en)
*
|
2013-03-14 |
2016-09-27 |
Novartis Ag |
Respirable agglomerates of porous carrier particles and micronized drug
|
|
AU2014228415B2
(en)
|
2013-03-15 |
2018-08-09 |
Mannkind Corporation |
Microcrystalline diketopiperazine compositions and methods
|
|
SG11201507286QA
(en)
|
2013-03-15 |
2015-10-29 |
Pearl Therapeutics Inc |
Methods and systems for conditioning of particulate crystalline materials
|
|
GB201305825D0
(en)
*
|
2013-03-28 |
2013-05-15 |
Vectura Ltd |
New use
|
|
US9393202B2
(en)
*
|
2013-04-26 |
2016-07-19 |
Chiesi Farmaceutici S.P.A |
Particle size reduction of an antimuscarinic compound
|
|
RS57799B1
(sr)
|
2013-07-11 |
2018-12-31 |
Chiesi Farm Spa |
Formulacija suvog praha za administriranje inhalacijom, koja obuhvata atniholinergik, kortikosteroid i beta-adrenergik
|
|
MX375448B
(es)
|
2013-07-18 |
2025-03-06 |
Mannkind Corp |
Composiciones farmacéuticas en polvo seco estables al calor y métodos.
|
|
US11446127B2
(en)
|
2013-08-05 |
2022-09-20 |
Mannkind Corporation |
Insufflation apparatus and methods
|
|
GEAP201814192A
(en)
*
|
2013-12-30 |
2018-02-26 |
Chiesi Farm Spa |
Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination
|
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
|
GB201415381D0
(en)
*
|
2014-08-29 |
2014-10-15 |
Algipharma As |
Inhalable powder formulations of alginate oligomers
|
|
DK3689332T3
(da)
|
2014-09-09 |
2026-03-23 |
Vectura Ltd |
Formulering, som omfatter glycopyrrolat, fremgangsmåde og apparat
|
|
CN105412049B
(zh)
*
|
2014-09-16 |
2020-01-07 |
四川海思科制药有限公司 |
一种干粉吸入剂用药物组合物及其制备方法
|
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
|
BR112017009315A2
(pt)
*
|
2014-11-05 |
2017-12-19 |
Glenmark Pharmaceuticals Ltd |
composição de pó seco farmacêutico inalável, processo para preparar uma composição de pó seco farmacêutico inalável, e, método para tratar transtornos respiratórios.
|
|
GB201515310D0
(en)
*
|
2015-08-27 |
2015-10-14 |
Jagotec Ag |
Pharmaceutical composition
|
|
US9925168B2
(en)
*
|
2016-01-22 |
2018-03-27 |
Chiesi Farmaceutici S.P.A. |
Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation
|
|
TWI745396B
(zh)
|
2016-07-12 |
2021-11-11 |
日商鹽野義製藥股份有限公司 |
吸入用醫藥組成物
|
|
WO2018167180A1
(en)
*
|
2017-03-15 |
2018-09-20 |
Vectura Limited |
Method and formulation
|
|
US10786450B2
(en)
*
|
2017-05-11 |
2020-09-29 |
Chiesi Farmaceutici S.P.A. |
Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
|
|
PL3621589T3
(pl)
*
|
2017-05-11 |
2021-12-06 |
Chiesi Farmaceutici S.P.A. |
Sposób wytwarzania preparatu suchego proszku obejmującego środek antycholinergiczny, kortykosteroid i środek beta-adrenergiczny
|
|
CN107213141A
(zh)
*
|
2017-06-09 |
2017-09-29 |
中国药科大学 |
用于吸入的药物组合物
|
|
CN109200034A
(zh)
*
|
2017-06-30 |
2019-01-15 |
正大天晴药业集团股份有限公司 |
一种可吸入干粉形式的组合物及其制备方法
|
|
CN116196298A
(zh)
*
|
2018-07-26 |
2023-06-02 |
四川海思科制药有限公司 |
一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用
|
|
CN111936124A
(zh)
*
|
2018-07-26 |
2020-11-13 |
四川海思科制药有限公司 |
一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用
|
|
KR102696616B1
(ko)
|
2018-12-21 |
2024-08-20 |
한미약품 주식회사 |
흡입 제형용 건조 분말 및 이의 제조방법
|
|
CN109745565B
(zh)
*
|
2019-01-28 |
2021-05-18 |
上海方予健康医药科技有限公司 |
一种用于吸入的干粉组合物及其制备方法
|
|
CA3150240A1
(en)
|
2019-09-24 |
2021-04-01 |
Tomaso GUIDI |
Dry powder formulation for a dry powder inhaler, with a combination of spheronised particles and coarse particles, and a dry powder inhaler comprising the formulation
|
|
CN116194087B
(zh)
*
|
2020-01-15 |
2025-07-11 |
四川海思科制药有限公司 |
一种含茚达特罗的吸入气雾剂药物组合物及其制备方法
|
|
CN114129545A
(zh)
*
|
2020-09-03 |
2022-03-04 |
博瑞生物医药（苏州）股份有限公司 |
一种吸入用药物组合物的制备方法及其产品
|